FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1530106857> ?p ?o ?g. }

• W1530106857 abstract "Minimal residual disease detection in the bone marrow is usually performed in patients with acute myeloid leukemia undergoing one course of induction chemotherapy. To optimize the chemotherapy strategies, more practical and sensitive markers are needed to monitor the early treatment response during induction. For instance, peripheral blood (PB) blast clearance rate may be considered as such a monitoring marker.PB blasts were monitored through multiparameter flow cytometry (MFC). Absolute counts were determined before treatment (D0) and at specified time points of induction chemotherapy (D3, D5, D7, and D9). The cut-off value of D5 peripheral blast clearance rate (D5-PBCR) was defined through receiver operating characteristic (ROC) analysis. Prognostic effects were compared among different patient groups according to D5-PBCR cut-off value.D5-PBCR cut-off value was determined as 99.55%. Prognostic analysis showed that patients with D5-PBCR ≥99.55% more likely achieved complete remission (94.6% vs. 56.1%, P < 0.001) and maintained a relapse-free status than other patients (80.56% vs. 57.14%, P = 0.027). Survival analysis revealed that relapse-free survival (RFS) and overall survival (OS) were longer in patients with D5-PBCR ≥99.55% than in other patients (two-year OS: 71.0% vs. 38.7%, P = 0.011; two-year RFS: 69.4% vs. 30.7%, P = 0.026). In cytogenetic-molecular intermediate-risk group, a subgroup with worse outcome could be distinguished on the basis of D5-PBCR (<99.55%; OS: P = 0.033, RFS: P = 0.086).An effective evaluation method of early treatment response was established by monitoring PB blasts through MFC. D5-PBCR cut-off value (99.55%) can be a reliable reference to predict treatment response and outcome in early stages of chemotherapy. The proposed marker may be used in induction regimen modification and help optimize cytogenetic-molecular prognostic risk stratification." @default.
• W1530106857 created "2016-06-24" @default.
• W1530106857 creator A5003256572 @default.
• W1530106857 creator A5025565899 @default.
• W1530106857 creator A5025570473 @default.
• W1530106857 creator A5026678424 @default.
• W1530106857 creator A5035831472 @default.
• W1530106857 creator A5049061801 @default.
• W1530106857 creator A5067338319 @default.
• W1530106857 creator A5067970407 @default.
• W1530106857 creator A5071374332 @default.
• W1530106857 creator A5073575024 @default.
• W1530106857 creator A5075668797 @default.
• W1530106857 creator A5077604881 @default.
• W1530106857 creator A5085959836 @default.
• W1530106857 creator A5086332136 @default.
• W1530106857 date "2015-05-10" @default.
• W1530106857 modified "2023-10-12" @default.
• W1530106857 title "Clinical significance of day 5 peripheral blast clearance rate in the evaluation of early treatment response and prognosis of patients with acute myeloid leukemia" @default.
• W1530106857 cites W1255676896 @default.
• W1530106857 cites W1546267208 @default.
• W1530106857 cites W1963777403 @default.
• W1530106857 cites W1981449355 @default.
• W1530106857 cites W1992419693 @default.
• W1530106857 cites W2013159744 @default.
• W1530106857 cites W2019523681 @default.
• W1530106857 cites W2043803673 @default.
• W1530106857 cites W2045974018 @default.
• W1530106857 cites W2048369602 @default.
• W1530106857 cites W2049000194 @default.
• W1530106857 cites W2051465651 @default.
• W1530106857 cites W2055739372 @default.
• W1530106857 cites W2069448515 @default.
• W1530106857 cites W2075043727 @default.
• W1530106857 cites W2076426515 @default.
• W1530106857 cites W2078041280 @default.
• W1530106857 cites W2078783659 @default.
• W1530106857 cites W2089596135 @default.
• W1530106857 cites W2092704641 @default.
• W1530106857 cites W2101278441 @default.
• W1530106857 cites W2104722860 @default.
• W1530106857 cites W2113507618 @default.
• W1530106857 cites W2117300586 @default.
• W1530106857 cites W2124159210 @default.
• W1530106857 cites W2125233997 @default.
• W1530106857 cites W2128541003 @default.
• W1530106857 cites W2132785906 @default.
• W1530106857 cites W2138265677 @default.
• W1530106857 cites W2142830602 @default.
• W1530106857 cites W2153382436 @default.
• W1530106857 cites W2158698691 @default.
• W1530106857 cites W2159363584 @default.
• W1530106857 cites W2163358530 @default.
• W1530106857 cites W2316323341 @default.
• W1530106857 cites W80054229 @default.
• W1530106857 cites W1966950462 @default.
• W1530106857 doi "https://doi.org/10.1186/s13045-015-0145-1" @default.
• W1530106857 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4431040" @default.
• W1530106857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25957890" @default.
• W1530106857 hasPublicationYear "2015" @default.
• W1530106857 type Work @default.
• W1530106857 sameAs 1530106857 @default.
• W1530106857 citedByCount "8" @default.
• W1530106857 countsByYear W15301068572016 @default.
• W1530106857 countsByYear W15301068572017 @default.
• W1530106857 countsByYear W15301068572018 @default.
• W1530106857 countsByYear W15301068572019 @default.
• W1530106857 countsByYear W15301068572020 @default.
• W1530106857 countsByYear W15301068572021 @default.
• W1530106857 crossrefType "journal-article" @default.
• W1530106857 hasAuthorship W1530106857A5003256572 @default.
• W1530106857 hasAuthorship W1530106857A5025565899 @default.
• W1530106857 hasAuthorship W1530106857A5025570473 @default.
• W1530106857 hasAuthorship W1530106857A5026678424 @default.
• W1530106857 hasAuthorship W1530106857A5035831472 @default.
• W1530106857 hasAuthorship W1530106857A5049061801 @default.
• W1530106857 hasAuthorship W1530106857A5067338319 @default.
• W1530106857 hasAuthorship W1530106857A5067970407 @default.
• W1530106857 hasAuthorship W1530106857A5071374332 @default.
• W1530106857 hasAuthorship W1530106857A5073575024 @default.
• W1530106857 hasAuthorship W1530106857A5075668797 @default.
• W1530106857 hasAuthorship W1530106857A5077604881 @default.
• W1530106857 hasAuthorship W1530106857A5085959836 @default.
• W1530106857 hasAuthorship W1530106857A5086332136 @default.
• W1530106857 hasBestOaLocation W15301068571 @default.
• W1530106857 hasConcept C126322002 @default.
• W1530106857 hasConcept C143998085 @default.
• W1530106857 hasConcept C146357865 @default.
• W1530106857 hasConcept C151730666 @default.
• W1530106857 hasConcept C194409129 @default.
• W1530106857 hasConcept C2776611710 @default.
• W1530106857 hasConcept C2776694085 @default.
• W1530106857 hasConcept C2776863199 @default.
• W1530106857 hasConcept C2778461978 @default.
• W1530106857 hasConcept C2778729363 @default.
• W1530106857 hasConcept C2779282312 @default.
• W1530106857 hasConcept C2779823535 @default.
• W1530106857 hasConcept C2780007613 @default.
• W1530106857 hasConcept C58471807 @default.
• W1530106857 hasConcept C71924100 @default.

• next